1[期刊论文]

Bis-(p-nitrophenylethyl)phosphoromonochloridate, a new versatile phosphorylating agent

作者：Frank Himmelsbach ;Wolfgang Pfleiderer

来源：Tetrahedron Letters. 1982 ;23(46):4793-4796.doi:10.1016/S0040-4039(00)85715-9

出版社：Elsevier BV

全文购买

2[期刊论文]

The use of the p-nitrophenylethoxycarbonyl group for amino protection in cytidine and adenosine chemistry

作者：Frank Himmelsbach ;Wolfgang Pfleiderer

来源：Tetrahedron Letters. 1983 ;24(34):3583-3586.doi:10.1016/S0040-4039(00)88174-5

出版社：Elsevier BV

全文购买

3[期刊论文]

Synthesis of new modified 2′,5′-adenylate trimers carrying 3′-amino-3′-deoxyadenosine at the 2′-terminus

作者：Wolfgang Pfleiderer ;Frank Himmelsbach ;Ramamurthy Charubala

来源：Bioorganic & Medicinal Chemistry Letters. 1994 ;4(8):1047-1052.doi:10.1016/S0960-894X(01)80679-X

出版社：Elsevier BV

全文购买

4[期刊论文]

Synthesis of 2-bromo-7-methyl-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one and 3-alkyl-2-bromo-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one and their selective elaboration

作者：Matthias Eckhardt ;Norbert Hauel ;Elke Langkopf 等

来源：Tetrahedron Letters. 2008 ;49(12):1931-1934.doi:10.1016/j.tetlet.2008.01.102

出版社：Elsevier BV

全文购买

5[期刊论文]

Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men

作者：Thomas H. Müller ;Hans Weisenberger ;Rolf Brickl 等

来源：Circulation. 1997 ;96(4):1130-1138.doi:10.1161/01.CIR.96.4.1130

出版社：Ovid Technologies (Wolters Kluwer Health)

全文购买

6[期刊论文]

The p-nitrophenylethyl (NPE) group

作者：Frank Himmelsbach ;Bernd S. Schulz ;Thomas Trichtinger 等

来源：Tetrahedron. 1984 ;40(1):59-72.doi:10.1016/0040-4020(84)85103-0

出版社：Elsevier BV

全文购买

7[期刊论文]

SGLT6 - A pharmacological target for the treatment of obesity?

作者：Tamara Baader-Pagler ;Matthias Eckhardt ;Frank Himmelsbach 等

来源：Adipocyte. 2018 ;7(4):277-284.doi:10.1080/21623945.2018.1516098

出版社：Taylor & Francis Group

全文购买

8[期刊论文]

3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors

作者：Matthias Eckhardt ;Norbert Hauel ;Frank Himmelsbach 等

来源：Bioorganic & Medicinal Chemistry Letters. 2008 ;18(11):3158-3162.doi:10.1016/j.bmcl.2008.04.075

出版社：Elsevier BV

全文购买

9[期刊论文]

8-（3-（R）-Aminopiperidin-1-yl）-7-but-2-ynyl-3-methyl-1-（4-methyl-quinazolin-2-ylmethyl）-3,7-dihydropurine-2,6-dione （BI 1356）, a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes

作者：Matthias Eckhardt ;Elke Langkopf ;Michael Mark 等

来源：Journal of Medicinal Chemistry. 2007 ;50(26):6450-6453.doi:10.1021/jm701280z

出版社：American Chemical Society

全文购买

10[期刊论文]

Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes

作者：Bradford S. Hamilton ;Frank Himmelsbach ;Herbert Nar 等

来源：European Journal of Pharmacology. 2015 ;746:50-55.doi:10.1016/j.ejphar.2014.10.053

出版社：Elsevier BV

全文购买